Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Completed1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed120%
withdrawn120%
recruiting240%
unknown120%

Recent Activity

2 active trials
Showing 5 of 5
completed

Registry of Patients With CardioMEMS

NCT02729922
recruitingnot_applicable

The CardioClip Study

NCT06241430
withdrawnnot_applicable

TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care

NCT04977310
recruitingnot_applicable

Patient SELF-management With HemodynamIc Monitoring: Virtual Heart Failure Clinic and Outcomes

NCT04441203
unknownphase_4

Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®

NCT04570865

Clinical Trials (5)

Showing 5 of 5 trials
NCT02729922

Registry of Patients With CardioMEMS

Completed
NCT06241430Not Applicable

The CardioClip Study

Recruiting
NCT04977310Not Applicable

TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care

Withdrawn
NCT04441203Not Applicable

Patient SELF-management With HemodynamIc Monitoring: Virtual Heart Failure Clinic and Outcomes

Recruiting
NCT04570865Phase 4

Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5